Trial Profile
Study of ALM301 in Oesophageal-gastric cancer patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs VAD 044 (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 29 Jul 2016 New trial record